Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Trimi Health vs RxSpan MD

Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, RxSpan MD a 86. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Trimi Health

#7 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Trimi Health review →
VS

RxSpan MD

#20 · Grade A- · Great Deal

Est. first month

$194/mo

Save ~86% vs brand-name
Get this deal Full RxSpan MD review →

The verdict

Better value: Trimi Health

Trimi Health takes it on Value Score, 89 to 86 an est. $99/mo first month, with no teaser step-up baked in. RxSpan MD isn't out of it: Shoppers who want a wide, doctor-fronted menu with upfront, all-inclusive pricing and nationwide coverage, and who don't mind that the lowest rate takes an annual commitment.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealTrimi HealthRxSpan MD
Value Score89 (A)86 (A-)
Est. first month$99/mo$194/mo
Save vs brand-name~93%~86%
Semaglutide$99/moFrom $194/mo
Tirzepatide$125/mo$329/mo
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesAll 50 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
80
Trimi Health: 95. RxSpan MD: 80.
84
No Teaser-Rate Bait
82
Trimi Health: 84. RxSpan MD: 82.
98
Nationwide Availability
96
Trimi Health: 98. RxSpan MD: 96.
94
Both Molecules
94
Trimi Health: 94. RxSpan MD: 94.
82
Easy Cancellation
88
Trimi Health: 82. RxSpan MD: 88.
70
Reputation
86
Trimi Health: 70. RxSpan MD: 86.

Trimi Health

The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.

Why it's a deal

  • Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
  • Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
  • Nationwide 50-state reach, so the low price isn't gated to a handful of states

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
  • Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
  • Newer brand with a thin public track record

RxSpan MD

A broad, physician-led menu — compounded and oral GLP-1 plus an advertised brand-name lane under a named plastic surgeon — with transparent, all-inclusive pricing from ~$194/mo (annual) across all 50 states.

Why it's a deal

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping, and support in one price; cancel or change plans anytime, with a low annual entry from ~$194/mo on compounded semaglutide
  • Both injectable and a real oral (capsule) route, on compounded sema/tirz plus an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz, plastic surgeon); 24/7 unlimited messaging and coaching, free shipping

The fine print

  • Compounded semaglutide/tirzepatide are not FDA-approved — not the same as Wegovy, Ozempic, or Zepbound
  • Published pricing shown is for the compounded line — brand-name pricing isn't itemized
  • Prescription isn't guaranteed — a provider reviews eligibility after checkout
Get the Trimi Health deal Get the RxSpan MD deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.